Protalix BioTherapeutics, Inc.

AMEX:PLX

1.4 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Operating Activities:
Net Income 8.312-14.927-27.582-6.523-18.276-26.457-85.276-29.176-27.282-29.943-27.79-11.618-36.529-28.998-31.44-22.414-22.481-9.39-0.075-0.16-0.141-0.15-0.329-0.106-0.998-1.1470.1180.132
Depreciation & Amortization 1.1911.0861.1181.3021.6171.6711.921.9832.373.143.5393.6923.6313.1331.991.3010.7590.5020000000.1630.20200
Deferred Income Tax -3.09200.813-0.522-0.068-0.06439.353-7.5911.5610.1150.1420.2436.873-0.617-0.218-3.032-11.714-3.46500000000-0.033-0.008
Stock Based Compensation 3.4482.0852.3753.1260.8350.5140.3370.9881.8021.2424.0897.7510.8861.2822.6833.07110.8453.4210000000000
Change In Working Capital -10.539-12.0159.901-27.13-6.83513.52529.1031.117-3.304-5.725-10.4960.7417.943-13.64171.1722.0111.0430.2690.002-0.008-00.003-0.3940.194-1.0820.5620.010.08
Accounts Receivables -0.428-1.194-1.0322.0910.188-3.0990.025-1.1330.523-0.7991.9040.2433.891-6.86-1.2240.6360.14-1.0310000000000
Inventory -2.2411.15-4.872-4.9270.414-0.736-2.5880.522-2.3161.29-3.918-3.760.91-1.18900000000000000
Accounts Payables 5.295-4.8042.5751.9112.143-0.524.9022.139-1.8730.954-1.3222.9776.147-1.0297.7841.3750.9031.30000000000
Other Working Capital -13.165-7.16713.23-26.205-9.5817.8826.764-0.4110.362-7.17-7.161.281-3.005-4.56364.612000000000000.010.08
Other Non Cash Items -0.638-1.2293.093.6413.3693.0694.5690.5810.5691.89-0.137-0.171-36.3740.3770.2653.04811.0993.572000.004-0-0.066-0.1410.508-0.526-0.344-0.244
Operating Cash Flow -1.318-25-10.285-26.106-19.358-7.742-9.994-32.098-24.284-29.281-30.6530.635-23.57-38.46444.452-16.015-10.449-5.091-0.072-0.168-0.137-0.147-0.789-0.053-1.408-0.91-0.248-0.041
Investing Activities:
Investments In Property Plant And Equipment -1.149-0.628-1.459-0.655-0.627-0.686-0.971-0.849-0.464-0.785-1.89-2.068-5.705-7.855-6.195-3.371-2.335-0.842000000-0.029-0.1400
Acquisitions Net 15.4200.0530000.0030.020.0030000000000000000000
Purchases Of Investments -20.42-16-37.835-2000000-0.09-0.212-0.218-0.165-0.137000-0.04700-0.55200-2.4-1.062-0.0590-6.324
Sales Maturities Of Investments 51157.83500000000000000000001.2172.2450000
Other Investing Activites -15.5620.5930.3270.703-0.2560.095-0.148-0.11839.851-0.126-0.212-0.2180.002-0.1370.021-0.33-0.103-0.09100.5520.0610.0390.0970.2271.623-3.6530.0320
Investing Cash Flow -16.711-5.03518.921-19.952-0.883-0.591-1.119-0.96739.387-1.001-2.102-2.286-5.868-7.992-6.174-3.701-2.438-0.9800.552-0.4910.0391.3140.0710.532-3.8530.032-6.324
Financing Activities:
Debt Repayment 00-34.122-0.2150-4.752-10.961-19.68100-66.7800000000000000-0.02100
Common Stock Issued 24.6668.23646.246.210000.0146.1010025.32820.65000.00558.6716.3670.494000000007.052
Common Stock Repurchased 000000000000000-0.056000000000000
Dividends Paid 0000000000000000000000000000
Other Financing Activities 0.7120.00242.1140.4720-4.7529.54219.6950.5340.04666.8921.230.2770.5010.293-0.051-0.1040.34100000-0.035-0.0065.98800
Financing Cash Flow 24.6668.23812.07846.4670-4.752-1.41919.6956.6350.04666.89226.55820.9270.5010.293-0.05158.56616.7080.4940000-0.035-0.0065.96707.052
Other Information:
Effect Of Forex Changes On Cash -0.114-0.0770.0060.0640.225-0.270.4140.277-0.131-1.3950.2260.127-0.3880.5890.0990.550.75600000000000
Net Change In Cash 6.523-21.87420.720.473-20.016-13.355-12.118-13.09321.607-31.63134.36325.034-8.899-45.36638.67-19.21746.43510.6370.4220.384-0.628-0.1080.525-0.017-0.8821.205-0.2160.688
Cash At End Of Period 23.63417.11138.98518.26517.79237.80851.16363.28176.37454.76786.39852.03527.00135.981.26642.59661.81315.3780.9850.5640.1790.8080.9160.3910.4071.2890.5480.764